Target intelligence / Profile preview

Tear film evaporation at air-liquid interface

Molecular classification
Other (not a molecule, receptor, enzyme, transporter, or canonical drug target)
01

Overview

“Tear film evaporation at the air–liquid interface" refers to the **physical process** by which water is lost from the precorneal tear film due to exposure to ambient air. The **tear film** itself is composed of three main layers—a superficial lipid layer derived primarily from meibomian gland secretions, an underlying aqueous layer rich in proteins and electrolytes, and an innermost mucin-rich layer adjacent to epithelial cells. The **lipid layer** plays a critical role in retarding water loss by forming a barrier at the air–liquid boundary; deficiencies or disruptions in this layer can lead to increased evaporation rates and are implicated in dry eye disease pathogenesis[1][3]. Experimental studies show that highly condensed wax ester-rich lipid layers are most effective at reducing evaporative loss; less organized or multi-component mixtures are less protective[3]. In vitro models using supported lipid bilayers with tunable mucin density have demonstrated that higher mucin coverage delays tear breakup time by providing additional hydration and stability against external disturbances[2]. The concept itself—evaporation at an "air-liquid interface"—describes a **biophysical phenomenon**, not a discrete molecular entity or canonical drug target such as an enzyme or receptor. It is therefore not considered a therapeutic "target" per se but rather represents an important physiological parameter relevant for understanding diseases like dry eye syndrome and for developing interventions aimed at restoring normal tear dynamics. In summary: "Tear film evaporation at air-liquid interface" describes an essential physical process affecting ocular health but does not correspond to any specific molecule, protein family, receptor type, or conventional drug target classification. It should be flagged as incorrect if used as such within structured pharmacological databases.[1][2][3]

Other names
Tear film evaporationEvaporation at air-liquid interfaceTear film stability (context-dependent)Air-liquid interface tear dynamics
02

Mechanism of action

Formation of lipid monolayers to retard water loss from the tear film by stabilizing the air–liquid interface and reducing evaporation[3][5]

03

Biological functions

Maintenance of ocular surface hydrationPrevention of tear film breakupProtection against environmental stressorsLubrication of the ocular surface[1][6]
04

Disease associations

Dry eye disease (DED)[4][5]Ocular surface disorders[1]
05

Safety considerations

Not applicable; this is not a molecular target but rather a biophysical process. However, therapeutic challenges include achieving effective reduction in tear evaporation without disrupting normal ocular physiology.
06

Interacting drugs

Miebo (perfluorohexyloctane), which forms a monolayer at the air–liquid interface to reduce evaporation[5]

1 more in the full profile.

07

Biomarkers

Tear breakup time (TBUT)Expression levels of mucins such as MUC16 and inflammatory markers like IL‑6 in experimental models[2][4]

Beyond the preview

Go deeper on Tear film evaporation at air-liquid interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tear film evaporation at air-liquid interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call